Navigation Links
FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
Date:12/13/2010

moderate intensity (greater than or equal to Grade 2) in the PREZISTA/ritonavir arm through 96 weeks were diarrhea (8%), headache (6%), abdominal pain (5%), and rash (5%)
  • In treatment-experienced adult patients, the most common adverse drug reactions (greater than or equal to 5%) reported of at least moderate intensity (greater than or equal to Grade 2) in the PREZISTA/ritonavir arm through 96 weeks were diarrhea (14%), nausea (7%), rash (7%), abdominal pain (6%), and vomiting (5%)
  • This is not a complete list of all adverse drug reactions reported with the use of PREZISTA/ritonavir.Please see accompanying full Prescribing Information for more details. Full prescribing information is also available at www.PREZISTA.com.You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

    About Tibotec PharmaceuticalsTibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Beerse, Belgium, with offices in Titusville, NJ, USA. Tibotec is dedicated to the discovery and development of innovative HIV-1/AIDS drugs and anti-infectives for diseases of high unmet medical need.

    About Tibotec TherapeuticsTibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., headquartered in Titusville, NJ, is dedicated to delivering innovative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV-1.

    (1) Resistance-associated mutations are also referred to as resistance-associated substitutions.Media Contact:  Pamela Van Houten, 609-730-7902 (office)908-295-7367 (mobile)Investor Contacts:  Louise Mehrotra, 732-524-6491 Stan Panasewicz, 732-524-2524
    '/>"/>

    SOURCE Tibotec Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
    2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
    3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
    4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
    5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
    6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
    7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
    8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
    9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
    10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
    11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2014)... BOSTON , December 15, 2014 ... and development company, is pleased to announce the grant ... States relating to its GPCR-focused drug discovery ... significantly strengthens the global patent estate covering Heptares, technologies ... The suite of patents recently granted by the US ...
    (Date:12/13/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ) ... Injection Devices to 2020" report to their ... As new drugs become available for ... conditions, drug developers have increasingly pursued packaging and ... increase the efficiency and reliability with which the ...
    (Date:12/13/2014)... , Dec. 12, 2014  Radiologists can ... to images, to their referring physicians, electronic health ... using carefully selected technology.  That ... Data Systems Corporation (ADS) at the recent Radiology ... The transmitting of radiology reports in this manner ...
    Breaking Medicine Technology:Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3
    ... Esperion Therapeutics, a privately held biotechnology company ... cardiovascular and metabolic diseases, today announced that it ... ETC-1002, the company,s lead product candidate. ETC-1002 is ... preclinical and clinical activity as a metabolic regulator ...
    ... 6, 2011 ChemoCentryx, Inc., today announced that Thomas ... present at J.P. Morgan,s 29 th Annual Healthcare ... Pacific at the Westin St. Francis Hotel in San ... ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused ...
    Cached Medicine Technology:Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002 2ChemoCentryx to Present at the 29th Annual J.P. Morgan Healthcare Conference 2
    (Date:12/15/2014)... SIMpalm, a leading mobile app development ... for its client, which allows users to keep track ... in finding the right wine. At the center ... sensory, chemistry and wine information. All this information is ... Those wines that are close counterparts to one another ...
    (Date:12/15/2014)... Boston, MA (PRWEB) December 15, 2014 ... health management solutions, announced today that it has ... for Quality Assurance (NCQA) for its Disease Management ... obstructive pulmonary disease (COPD), coronary heart disease and ... accreditation from NCQA for Health Dialog’s Disease Management ...
    (Date:12/15/2014)... 14, 2014 (HealthDay News) -- Expert pilots process visual ... why they make better decisions during landings, a new ... difficult techniques for pilots to master, and 36 percent ... crashes occur during final approach and landing. Researchers ... 12 moderately experienced pilots while they were at the ...
    (Date:12/15/2014)... CT (PRWEB) December 15, 2014 Kathy ... the prestigious Women World Awards in the category of ... a gold award for her weekly career blog ... practical advice to help professionals elevate their talent and ... Her blog, named after her book Networking Ahead for ...
    (Date:12/15/2014)... In support of high-quality independent ... restrictive state laws that may have unintended consequences ... area of public health policy. , The position ... of Independent Review, contends that state legislation that ... review determinations can result in subpar outcomes for ...
    Breaking Medicine News(10 mins):Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2
    ... University of Pennsylvania School of Medicine discovered that proteins ... exposed to the tau protein, which plays an important ... proteins transport cellular cargo towards opposite ends of tracks ... acts like a speed bump to regulate protein traffic, ...
    ... CHICAGO, Jan. 17 Bankers Life and Casualty Company ... Health and Human,Services in implementing a study with senior ... over age 65 fall each year, and falls,are a ... cause of nonfatal,injuries," said Scott Perry, president of Bankers, ...
    ... answer may depend on outcomes of ongoing clinical trials, expert ... reports that statins might slow or prevent Alzheimer,s disease, a ... While some animal studies have suggested this possibility, whether the ... said. , "We didn,t find a relation between statin ...
    ... researchers say , , THURSDAY, Jan. 17 (HealthDay News) -- By ... say they,re gaining new insight into how some children are ... report in a new study that both twins -- one ... that mutated and became precancerous. In one of the twins, ...
    ... ... young children., BERKELEY SPRINGS, W.Va., Jan. 17 The US ... is too risky,for babies and toddlers on Thursday according to recent ... parents of the serious and,potentially life threatening side effects of cold ...
    ... for Life-Threatening, Genetic,Disease, WASHINGTON, Jan. 17 All ... beginning today. Montana is the,37th state in the country, ... states that support routine CF screening at birth., ... states dedicated,to supporting newborn screening for cystic fibrosis," said ...
    Cached Medicine News:Health News:Alzheimer's molecule is a smart speed bump on the nerve-cell transport highway 2Health News:Bankers Life and Casualty Company Joins LifePlans, Inc. and the Department of Health and Human Services to Launch Fall Prevention Program Study For America's Seniors 2Health News:Latest Study Says Statins Don't Slow Alzheimer's 2Health News:Study Gets Closer to Origins of Leukemia 2Health News:FDA to Declare Cold Medicines Too Risky, Homeopathy Offers a Safe Alternative 2Health News:Montana Passes Newborn Screening Law for Cystic Fibrosis 2
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medicine Products: